Lisa Jackson

Researcher

UAMS

Also affiliated: San Jose State University (2014)

Faculty Researcher

9 h-index 14 pubs 914 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Lisa Jackson's research has focused on health sciences, with a particular emphasis on child and adolescent health. Her work has explored various aspects of public health, including health disparities and outcomes. Jackson has also investigated behavioral and psychological studies related to health. Her most recent publication was in 2014, indicating a period of reduced recent activity.

Metrics

h-index: 9
Publications: 14
Citations: 914

Selected Publications

Delay discounting rates: A strong prognostic indicator of smoking relapse (2014)

Addictive Behaviors 164 citations DOI OpenAlex
Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence. (2014)

Journal of Consulting and Clinical Psychology 161 citations DOI OpenAlex
Discounting of money and sex: Effects of commodity and temporal position in stimulant-dependent men and women (2014)

Addictive Behaviors 81 citations DOI OpenAlex
Delay Discounting, Locus of Control, and Cognitive Impulsiveness Independently Predict Tobacco Dependence Treatment Outcomes in a Highly Dependent, Lower Socioeconomic Group of Smokers (2012)

American Journal on Addictions 263 citations DOI OpenAlex
Single- and cross-commodity discounting among cocaine addicts: the commodity and its temporal location determine discounting rate (2011)

Psychopharmacology 112 citations DOI OpenAlex
Hypothetical intertemporal choice and real economic behavior: Delay discounting predicts voucher redemptions during contingency-management procedures. (2010)

Experimental and Clinical Psychopharmacology 66 citations DOI OpenAlex
Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine. (2009)

Experimental and Clinical Psychopharmacology 26 citations DOI OpenAlex
Total Therapy 2 (TT2) for Multiple Myeloma (MM): Thalidomide (T) Effects Superior Complete Response (CR) and Event-Free Survival (EFS); Similar Overall Survival (OS) Linked to Shorter Post-Relapse Survival. (2005)

Blood 7 citations DOI OpenAlex
Metaphase Cytogenetic Abnormalities (M-CA) and Interphase FISH for Deletion 13 (FISH 13) in Total Therapy 2 (TT 2): Follow up Observation among? 380 Patients with Newly Diagnosed Multiple Myeloma (MM). (2004)

Blood DOI OpenAlex